​

Lifecore Biomedical (LFCR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LFCR Stock Forecast

Lifecore Biomedical (LFCR) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 6.19% increase from the last price of $5.65.

$4 $5 $6 $7 $8 $9 High: $6 Avg: $6 Low: $6 Last Closed Price: $5.65

LFCR Stock Rating

Lifecore Biomedical stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

LFCR Price Target Upside V Benchmarks

TypeNameUpside
StockLifecore Biomedical6.19%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks22.20%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$6.00$6.00
Last Closing Price$5.65$5.65$5.65
Upside/Downside-6.19%6.19%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26122--5
May, 26122--5
Apr, 26122--5
Mar, 26-23--5
Feb, 26-23--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 29, 2026Barrington$6.00$5.1217.19%6.19%
Oct 04, 2024Jacob JohnsonStephens$5.00$5.38-7.06%-11.50%
Sep 05, 2024Matthew HewittCraig-Hallum$8.00$4.2289.57%41.59%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 29, 2025KeyBancSector WeightSector Weighthold
Sep 04, 2025KeyBancSector Weightinitialise
May 21, 2025William BlairOutperforminitialise
Nov 22, 2024Craig-HallumBuyBuyhold
Oct 04, 2024StephensEqual-WeightEqual-Weighthold
Sep 05, 2024Craig-HallumBuyinitialise

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 May 22 May 23 May 24 May 25 May 26 May 27
May 22May 23May 24May 25May 26May 27
Reported$-1.56$-3.41$0.39---
Avg Forecast$-1.98$-2.38$0.41$-0.90$-0.63$-0.43
High Forecast$-1.94$-2.34$0.41$-0.88$-0.52$-0.40
Low Forecast$-2.00$-2.41$0.40$-0.92$-0.72$-0.45
Surprise %-21.21%43.28%-4.88%---

Revenue Forecast

$100M $118M $136M $154M $172M $190M May 22 May 23 May 24 May 25 May 26 May 27
May 22May 23May 24May 25May 26May 27
Reported$185.79M$103.27M$128.26M---
Avg Forecast$183.76M$121.88M$125.39M$128.61M$138.69M$156.83M
High Forecast$185.30M$122.96M$126.51M$129.76M$139.93M$157.94M
Low Forecast$181.24M$120.34M$123.81M$126.99M$136.94M$155.72M
Surprise %1.10%-15.27%2.29%---

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M May 22 May 23 May 24 May 25 May 26 May 27
May 22May 23May 24May 25May 26May 27
Reported$-46.08M$-102.19M$12.01M---
Avg Forecast$-72.46M$-87.04M$14.99M$-32.95M$-22.81M$-16.07M
High Forecast$-71.17M$-85.82M$15.20M$-32.13M$-19.14M$-14.66M
Low Forecast$-73.25M$-88.26M$14.78M$-33.77M$-26.48M$-16.50M
Surprise %-36.40%17.41%-19.88%---

LFCR Forecast FAQ

Is Lifecore Biomedical stock a buy?

Lifecore Biomedical stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lifecore Biomedical is a favorable investment for most analysts.

What is Lifecore Biomedical's price target?

Lifecore Biomedical's price target, set by 7 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 6.19% change from the previous closing price of $5.65.

How does Lifecore Biomedical stock forecast compare to its benchmarks?

Lifecore Biomedical's stock forecast shows a 6.19% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (22.20%).

What is the breakdown of analyst ratings for Lifecore Biomedical over the past three months?

  • June 2026: 20.00% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 20.00% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 20.00% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is Lifecore Biomedical’s EPS forecast?

Lifecore Biomedical's average annual EPS forecast for its fiscal year ending in May 2025 is $-0.9, marking a -330.77% decrease from the reported $0.39 in 2024. Estimates for the following years are $-0.63 in 2026, and $-0.43 in 2027.

What is Lifecore Biomedical’s revenue forecast?

Lifecore Biomedical's average annual revenue forecast for its fiscal year ending in May 2025 is $128.61M, reflecting a 0.27% increase from the reported $128.26M in 2024. The forecast for 2026 is $138.69M, and $156.83M for 2027.

What is Lifecore Biomedical’s net income forecast?

Lifecore Biomedical's net income forecast for the fiscal year ending in May 2025 stands at $-32.95M, representing a -374.29% decrease from the reported $12.01M in 2024. Projections indicate $-22.813M in 2026, and $-16.075M in 2027.